Abstract
One of the aims of neoadjuvant chemotherapy in locally advanced breast cancer is to reduce tumor dimension, allowing tumor resection. Although most patients present clinical objective response, around 10-20% present complete pathological response or tumor progression. Tumor resistance may be characterized as intrinsic, when stable or progressive diseases are observed or acquired when afte…